Objective: To provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources such as the National Institutes of Health (NIH).
Senior Research Awards Costs: Total maximum award per year: $130,000 (subject to annual progress report approval).
Clinical relevance & translational impact: CCF emphasizes studies addressing pragmatic clinical questions that can be implemented in practice and appear in high-impact journals or guidelines .
Focus on IBD challenges: Projects aligned with the “Challenges in IBD Research” priorities (e.g., personalized medicine, microbiome, health disparities) receive top priority .
Career Development Awards: Best suited for early-career researchers (≤10 years post-degree) with relevant IBD experience, committed to building independent careers .
Senior Research Awards: Target established investigators with proven track records and preliminary data; fund pilots to support larger NIH-style proposals .
Well-defined hypotheses, appropriate sample sizes, clear timelines, and realistic milestones are essential .
For clinical awards, demonstrated potential to generate influential publications or guide clinical practice is crucial .
Career Development and Fellowship awards require a committed mentor and evidence of protected research time (e.g., ≥80%) .
Senior awards and clinical investigator grants should include institutional backing, core facilities access, and interdepartmental or multicenter collaboration .
Projects that pioneer personalized approaches—like biomarker-driven treatment selection or new delivery systems—especially when moving toward practice change, perform well .
Innovative product development (e.g., IBD Ventures Smart Pills) reflects CCF’s interest in real-world solutions .
Senior Research Award proposals should lay out how generated data will form the basis for larger NIH or foundation funding .
Expectation: funded work leads to high-impact publications, clinical guideline citations, and "follow-on" grants
All grants undergo rigorous peer review by IBD experts; quality of science, relevance, innovation, and feasibility are evaluated .
📋 Summary Table
Grant Type | Key Predictors of Success |
---|---|
Career Development / Fellowship | Early-stage, strong mentorship, protected time (≥80%), IBD focus |
Senior Research Award | Proven track record, preliminary data, translational potential, scalability |
Clinical Investigator-Initiated | Clinical relevance, practice impact, alignment with priority areas |
IBD Ventures / Litwin Pioneers | Innovative product development or new clinical tools |
✅ Tips to Strengthen Your CCF Application
Frame your project within the “Challenges in IBD Research” framework to show mission alignment.
Build a strong mentorship team, especially for junior awards, specifying roles and time commitment.
Develop clear milestones, sample size rationale, and time-structured aims.
Highlight translational impact—how it will change practice, lead to guidelines, or inform policy.
Plan for the future—lay out the grant pathway to NIH or similar agencies.
Demonstrate innovation via product or data platform development when applicable.
Ensure institutional support, with confirmed resources and collaborations included.
Applicant must hold an MD and/or PhD (or equivalent degree) and must be employed by an institution (public non-profit, private non-profit, or government) that is engaged in health care and/or health-related research. He/she must have attained independence from his/her mentor. Eligibility is not restricted by citizenship or geography.
Proposal Eligibility: Proposal must be relevant to Inflammatory Bowel Disease (IBD) or Crohn's disease and/or ulcerative colitis. Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Training Award is not permitted.
Sponsor Institute/Organizations: Crohn's & Colitis Foundation of America
Sponsor Type: Corporate/Non-Profit
Address: 733 THIRD AVENUE, SUITE 510, NEW YORK, NY 10017
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jul 18, 2025
Jul 18, 2025
$130,000
Affiliation: Crohn's & Colitis Foundation of America
Address: 733 THIRD AVENUE, SUITE 510, NEW YORK, NY 10017
Website URL: https://www.crohnscolitisfoundation.org/research/grants-fellowships/senior-research-awards
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.